Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,341 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mechanism of mitosis-specific activation of MEK1.
Harding A, Giles N, Burgess A, Hancock JF, Gabrielli BG. Harding A, et al. Among authors: burgess a. J Biol Chem. 2003 May 9;278(19):16747-54. doi: 10.1074/jbc.M301015200. Epub 2003 Feb 27. J Biol Chem. 2003. PMID: 12609978
The EBNA-3 gene family proteins disrupt the G2/M checkpoint.
Krauer KG, Burgess A, Buck M, Flanagan J, Sculley TB, Gabrielli B. Krauer KG, et al. Among authors: burgess a. Oncogene. 2004 Feb 19;23(7):1342-53. doi: 10.1038/sj.onc.1207253. Oncogene. 2004. PMID: 14716295
Inhibition of S/G2 phase CDK4 reduces mitotic fidelity.
Burgess A, Wigan M, Giles N, Depinto W, Gillespie P, Stevens F, Gabrielli B. Burgess A, et al. J Biol Chem. 2006 Apr 14;281(15):9987-95. doi: 10.1074/jbc.M512714200. Epub 2006 Feb 13. J Biol Chem. 2006. PMID: 16476733
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.
Vennin C, Chin VT, Warren SC, Lucas MC, Herrmann D, Magenau A, Melenec P, Walters SN, Del Monte-Nieto G, Conway JR, Nobis M, Allam AH, McCloy RA, Currey N, Pinese M, Boulghourjian A, Zaratzian A, Adam AA, Heu C, Nagrial AM, Chou A, Steinmann A, Drury A, Froio D, Giry-Laterriere M, Harris NL, Phan T, Jain R, Weninger W, McGhee EJ, Whan R, Johns AL, Samra JS, Chantrill L, Gill AJ, Kohonen-Corish M, Harvey RP, Biankin AV; Australian Pancreatic Cancer Genome Initiative (APGI), Evans TR, Anderson KI, Grey ST, Ormandy CJ, Gallego-Ortega D, Wang Y, Samuel MS, Sansom OJ, Burgess A, Cox TR, Morton JP, Pajic M, Timpson P. Vennin C, et al. Among authors: burgess a. Sci Transl Med. 2017 Apr 5;9(384):eaai8504. doi: 10.1126/scitranslmed.aai8504. Sci Transl Med. 2017. PMID: 28381539 Free PMC article.
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer.
Chou A, Froio D, Nagrial AM, Parkin A, Murphy KJ, Chin VT, Wohl D, Steinmann A, Stark R, Drury A, Walters SN, Vennin C, Burgess A, Pinese M, Chantrill LA, Cowley MJ, Molloy TJ; Australian Pancreatic Cancer Genome Initiative (APGI), Waddell N, Johns A, Grimmond SM, Chang DK, Biankin AV, Sansom OJ, Morton JP, Grey ST, Cox TR, Turchini J, Samra J, Clarke SJ, Timpson P, Gill AJ, Pajic M. Chou A, et al. Among authors: burgess a. Gut. 2018 Dec;67(12):2142-2155. doi: 10.1136/gutjnl-2017-315144. Epub 2017 Oct 28. Gut. 2018. PMID: 29080858 Free PMC article.
1,341 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page